First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
This grant opportunity aims to support early-stage clinical trials for new drugs or medical devices targeting psychiatric disorders, especially in areas where current treatments are lacking. It focuses on assessing these drugs or devices in both children and adults, through trials that determine their effects, safety, and tolerability in the central nervous system. The trials include First-in-…
Although many promising novel therapeutic targets for treating psychiatric disorders have been discovered in recent years, the translation into effective treatments has been unacceptably slow. For those interventions advancing to clinical testing, the success rate of new drug and device approval…
Funding Source
Awards & funding
Eligibility
Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Required registrations (must be compl…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers